Device Trial Radar · NCT05686278
Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
368
Planned (sponsor's estimate)
Start
Jun 29, 2023
Primary completion
Sep 2028
Study completion Sep 2035
Sponsor
- Lead sponsor
- CorinNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 17, 2023
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This PMCF study is designed to collect safety and efficacy data on hip hemiarthroplasty surgeries with Corin BiPolar-i shell and the Oceane+ or Meije Duo femoral stem up to 10 years.
Conditions
- Hip Fractures
- Hip Hemiarthroplasty
- Osteoarthritis, Hip
- Avascular Necrosis of Hip
- Femoral Neck Fractures
Interventions
Bipolar i and cemented stem (Océane+ or Meije)Device
Hip hemiarthroplasty is a surgical procedure that involves replacing half of the hip joint
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of safety of the study devices at 2 years after a hip hemiarthroplasty surgery.Time frame: 2 years
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Polyclinique Henin Beaumont
Hénin-Beaumont, France · Terminated
Hopital Saint Joseph
Paris, France · Recruiting
Hopital Diaconesses Croix Saint Simon
Paris, France · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.